158 related articles for article (PubMed ID: 9381286)
1. [Study of bone marrow changes using marrow immunography].
Carrió Gasset I; Berná Roqueta L
Sangre (Barc); 1997 Aug; 42(4):295-9. PubMed ID: 9381286
[No Abstract] [Full Text] [Related]
2. Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer.
Lacić M; Bokulić T; Lukac J; Kovacić K; Baum RP; Kusić Z
Nucl Med Commun; 1999 Feb; 20(2):135-43. PubMed ID: 10088162
[TBL] [Abstract][Full Text] [Related]
3. Improved diagnosis of advanced bone marrow metastases by means of radiolabeled antigranulocyte antibodies.
von Mallek D; Joe A; Palmedo H; Matthies A; Biersack HJ; Reinhardt MJ
J Exp Clin Cancer Res; 2002 Sep; 21(3):421-4. PubMed ID: 12385588
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m labelled anti CD 66 antigranulocyte antibody imaging for assessment of bone marrow reserve.
Matthies A; Reinhardt M; Palmedo H; Ezziddin S; Abramowski B; Kuhn W; Biersack HJ; von Mallek D
Cancer Invest; 2005; 23(2):119-22. PubMed ID: 15813503
[TBL] [Abstract][Full Text] [Related]
5. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy.
Lee KH; Chung JK; Choi CW; Jeong JM; Lee DS; Bang YJ; Lee MC; Kim NK; Koh CS
J Nucl Med; 1995 Oct; 36(10):1800-5. PubMed ID: 7562046
[TBL] [Abstract][Full Text] [Related]
7. [Uptake of anti-CEA monoclonal antibody labeled with 99mTc in a patient with Paget's disease during a study of sigmoid cancer relapse].
Fuster D; Mateos JJ; Martín F; Pons F; Ortega M
Rev Esp Med Nucl; 2001 Oct; 20(6):473-4. PubMed ID: 11578583
[No Abstract] [Full Text] [Related]
8. Monoclonal antibodies to detect breast cancer cells in bone marrow.
Diel IJ; Kaufmann M; Costa SD; Bastert G
Important Adv Oncol; 1994; ():143-64. PubMed ID: 8206487
[No Abstract] [Full Text] [Related]
9. [Massive skeletal metastasis: difficulties of bone scintigraphy, contribution of medullary scintigraphy].
Blocklet D; Schoutens A
Rev Med Brux; 1999 Apr; 20(2):A104-5. PubMed ID: 10335106
[No Abstract] [Full Text] [Related]
10. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
11. [Pathologic diagnosis of nonhematological tumor metastasis in bone marrow by marrow aspiration and trephine biopsy].
Tao Y; Li X; Wu LY; Liu YZ; Song LX; Chang CK; Pu Q
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):112-3. PubMed ID: 20388377
[No Abstract] [Full Text] [Related]
12. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U
Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458
[TBL] [Abstract][Full Text] [Related]
13. Breast mucin and associated antigens in diagnosis and therapy.
Peterson JA; Ceriani RL
Adv Exp Med Biol; 1994; 353():1-8. PubMed ID: 7527177
[No Abstract] [Full Text] [Related]
14. Marrow scintigraphic changes after hormonal therapy.
Bourgeois P; Malarme M; Wauters E; Van Frank R; Ferremans W
J Nucl Med; 1992 Jul; 33(7):1427-8. PubMed ID: 1613591
[No Abstract] [Full Text] [Related]
15. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
Ivancevic V; Huic D; Wolter A; Munz DL
Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
[TBL] [Abstract][Full Text] [Related]
16. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Braun S; Müller M; Hepp F; Schlimok G; Riethmüller G; Pantel K
J Natl Cancer Inst; 1998 Jul; 90(14):1099-101. PubMed ID: 9672259
[No Abstract] [Full Text] [Related]
17. Bone marrow immunoscintigraphy versus conventional bone scintigraphy in the diagnosis of skeletal metastases in urogenital malignancies.
Zoeller G; Sandrock D; Munz DL; Ringert RH
Eur Urol; 1994; 26(2):141-4. PubMed ID: 7957469
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
[TBL] [Abstract][Full Text] [Related]
19. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
[TBL] [Abstract][Full Text] [Related]
20. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance.
Berná L; Torres G; Carrió I; Estorch M; Germá JR; Alonso C
Clin Nucl Med; 1994 Feb; 19(2):121-8. PubMed ID: 8187396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
